Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | President, Global Biopharma | May 10, 2023 | May 11, 2023 |
| UNITED PARCEL SERVICE INCUPS · Entity 2301 | Director | May 07, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date May 10, 2023 · Filed May 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 69,046 |
Reported balance
After 2023-05-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-05-10 · Other · Acquired 33,943 · Balance 69,046 F1: Each unit represents one phantom share of common stock. F2: This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F3: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
UNITED PARCEL SERVICE INC
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,362.7884 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 1,948 · Balance 10,362.7884 F1: One unit is equivalent to one share of UPS Class A common stock. F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3: Includes units credited upon the payment of dividends on the underlying Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: One unit is equivalent to one share of UPS Class A common stock.
F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director.
F3: Includes units credited upon the payment of dividends on the underlying Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 8, 2026 20:31 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005031 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,362.7884 Underlying: Class A Common Stock · 1,948 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:08 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004906 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,870.6982 Underlying: Class A Common Stock · 2,011 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:21 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005548 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,569.0073 Underlying: Class A Common Stock · 1,256 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 10, 2023 Filed May 11, 2023 22:46 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 33,943 | $38.30 | $1,300,016.90 |
DisclosureSEC source: 0001225208-23-005759 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · President, Global Biopharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,046 Underlying: Common Stock · 33,943 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 04, 2023 Filed May 5, 2023 21:19 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005495 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,143.153 Underlying: Class A Common Stock · 1,038 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 20,273 | $0.00 Strike: $22.89 | $0.00 |
DisclosureSEC source: 0001225208-23-002984 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · President, Global Biopharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,273 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,015 | $43.44 | $391,611.60 |
DisclosureSEC source: 0001225208-23-002984 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · President, Global Biopharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,778 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,748 | $41.75 | $239,979.00 |
DisclosureSEC source: 0001225208-23-002984 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · President, Global Biopharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,793 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 24, 2023. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 20,273 | $22.89 | $464,048.97 |
DisclosureSEC source: 0001225208-23-002984 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · President, Global Biopharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 89,920 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · derivative · entry 8 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,920 Underlying: Common Stock · 89,920 shares Expires 2030-02-23 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 103,320 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · derivative · entry 7 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,320 Underlying: Common Stock · 103,320 shares Expires 2028-02-23 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 57,032 | $0.00 Strike: $30.17 | $0.00 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,032 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 34,718 | $43.70 | $1,517,176.60 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,268 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 8,041 | $42.38 | $340,777.58 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,986 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:34 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 57,032 | $30.17 | $1,720,655.44 |
DisclosureSEC source: 0001225208-23-002832 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · President, Global Biopharmaceu 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:18 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006708 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,004.6151 Underlying: Class A Common Stock · 973 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:02 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 12,716 | $0.00 Strike: $25.60 | $0.00 |
DisclosureSEC source: 0001225208-22-003664 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,716 shares Expires 2022-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:02 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,937 | $50.64 | $300,649.68 |
DisclosureSEC source: 0001225208-22-003664 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,995 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:02 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,461 | $47.72 | $165,158.92 |
DisclosureSEC source: 0001225208-22-003664 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,932 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 25, 2022. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:02 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 12,716 | $25.60 | $325,529.60 |
DisclosureSEC source: 0001225208-22-003664 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 83,637 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · derivative · entry 8 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,637 Underlying: Common Stock · 83,637 shares Expires 2029-02-24 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 95,095 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · derivative · entry 7 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,095 Underlying: Common Stock · 95,095 shares Expires 2027-02-24 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 21,359 | $0.00 Strike: $27.34 | $0.00 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,359 shares Expires 2022-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 10,572 | $51.28 | $542,132.16 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,677 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,110 | $46.87 | $192,635.70 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:10 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 21,359 | $27.34 | $583,955.06 |
DisclosureSEC source: 0001225208-22-003467 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:32 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 18,098 | $49.73 | $900,013.54 |
DisclosureSEC source: 0001225208-21-013881 · doc4.xml · derivative · entry 7 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,576 Underlying: Common Stock · 18,098 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · shares: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F4 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F4 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:32 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 11,312 | $49.60 | $561,075.20 |
DisclosureSEC source: 0001225208-21-013881 · doc4.xml · nonDerivative · entry 4 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:32 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 10,646 | $49.59 | $527,935.14 |
DisclosureSEC source: 0001225208-21-013881 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,313 Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:32 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,412 | $49.62 | $169,303.44 |
DisclosureSEC source: 0001225208-21-013881 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,959 Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:32 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 800 | $49.61 | $39,688.00 |
DisclosureSEC source: 0001225208-21-013881 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,371 Read SEC document |
| May 13, 2021 Filed May 17, 2021 21:38 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008228 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,986.6975 Underlying: Class A Common Stock · 811 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 9,886 | $0.00 Strike: $22.35 | $0.00 |
DisclosureSEC source: 0001225208-21-004304 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,886 shares Expires 2021-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,268 | $34.64 | $217,123.52 |
DisclosureSEC source: 0001225208-21-004304 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,171 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,772 | $33.49 | $59,344.28 |
DisclosureSEC source: 0001225208-21-004304 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,439 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 26, 2021. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 9,886 | $22.35 | $220,952.10 |
DisclosureSEC source: 0001225208-21-004304 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 136,537 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · derivative · entry 8 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,537 Underlying: Common Stock · 136,537 shares Expires 2028-02-25 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 158,023 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · derivative · entry 7 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,023 Underlying: Common Stock · 158,023 shares Expires 2026-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 22,686 | $0.00 Strike: $22.89 | $0.00 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,686 shares Expires 2021-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 14,682 | $34.76 | $510,346.32 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,325 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,920 | $33.82 | $132,574.40 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,007 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:01 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 22,686 | $22.89 | $519,282.54 |
DisclosureSEC source: 0001225208-21-004041 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 01:09 UTC | PFIZER INC PFE · Entity 2863 | OtherCommon Stock | 12,970 | $37.84 | $490,784.80 |
DisclosureSEC source: 0001225208-20-014833 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 26,697 F1 · shares: This transaction constitutes an intra-plan transfer into the Pfizer Inc. stock fund under the Pfizer's Qualified Savings Plan. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 20:51 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009765 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154 Underlying: Class A Common Stock · 1,154 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS class A common stock. F2 · derivative.expiration_date: RSUs are fully vested on the date of the grant and are required to be held by the director until he or she separates from the board, at which time the RSUs are paid out in shares of class A common stock. Read SEC document |
| February 27, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 145,969 | $0.00 Strike: $34.10 | $0.00 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · derivative · entry 9 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,969 Underlying: Common Stock · 145,969 shares Expires 2027-02-27 F10 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F10 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 27, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 170,368 | $0.00 Strike: $34.10 | $0.00 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · derivative · entry 8 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,368 Underlying: Common Stock · 170,368 shares Expires 2025-02-27 F9 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F9 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 14,493 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · derivative · entry 7 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,493 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 3,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · derivative · entry 6 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164 Underlying: Common Stock · 3,164 shares Expires not disclosed F6 · derivative.exercise_price: Each unit represents one phantom share of common stock. F7 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan. F8 · derivative.exercise_date: The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F8 · derivative.expiration_date: The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 11,063 | $36.80 | $407,118.40 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,241 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,166 | $34.72 | $40,483.52 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,304 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.